EDITORIAL
Published on 18 Nov 2014
“Omics” and Immunologic Approaches to Optimizing Cure Rates in HER2-Positive Breast Carcinomas
doi 10.3389/fonc.2014.00334
- 2,108 views
- 1 citation
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Research Topics
- HER2-targeted therapy: an ongoing challenge
HER2-targeted therapy: an ongoing challenge
7,124
Total downloads
35k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 10 Jun 2013
Preclinical HER-2 Vaccines: From Rodent to Human HER-2
doi 10.3389/fonc.2013.00151
- 3,328 views
- 7 citations
REVIEW
Published on 21 May 2013
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
doi 10.3389/fonc.2013.00129
- 15,120 views
- 82 citations
MINI REVIEW
Published on 14 May 2013
Tailoring DNA Vaccines: Designing Strategies Against HER2-Positive Cancers
doi 10.3389/fonc.2013.00122
- 4,485 views
- 20 citations
REVIEW
Published on 23 Apr 2013
Activating Mutations in ERBB2 and Their Impact on Diagnostics and Treatment
doi 10.3389/fonc.2013.00086
- 23,668 views
- 68 citations
Published in
Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Pharmacology
Cancer Molecular Targets and TherapeuticsOffline
- 4.4 impact factor
- 7.8 citescore
Impact
- 35kTopic views
- 26kArticle views
- 7,124Article downloads